Thu, Oct 31, 2024
USFDA's VAI classification boosts Cipla’s outlook for niche drug launches, including Abraxane generic
More >
'Diwali Offer' Stocks by Anil Singhvi: Stock markets have been very volatile in last one month. Benchmark equity indices Sensex and Nifty fell in early trade even Thursday i.e. October 31, 2024. Amid this, investors are looking for stocks that can offer good return in long term.
Tue, Oct 29, 2024
Zee Business forecasts indicate a three percent year-on-year revenue increase, with Cipla’s Q2 revenue expected at Rs 6,892 crore, up from Rs 6,678 crore in the same quarter last year
Mon, Feb 20, 2023
What are the objections of US FDA on Cipla's plant? How much shares fell due to US FDA objections? Know full details from Nupur.
Cipla share price today BSE, NSE: Cipla shares suffered steep losses on Monday after the drug maker said US health regulator had issued eight observations on its manufacturing facility in Pitampur, Madhya Pradesh. The Cipla stock fell by as much as Rs 69.6 or 6.8 per cent to Rs 956.2 apiece on BSE.
Brokerages are bullish on celebrity investor Rekha Jhunjhunwala-owned Fortis Healthcare citing the company's good growth outlook. They are divided on telecom stocks such as Bharti Airtel and Indus Towers, and skeptical on energy company stocks such as BPCL and ONGC.
Which 20 stocks are included in the list today including Berger Paints, Cipla, JSPL and Eicher Motors? Know list of 20 stocks for profitable trade from Varun Dubey and Kushal Gupta on Traders Diary.
Stock Market HIGHLIGHTS: Indian equity benchmarks Sensex and Nifty50 finished a volatile session in the red on Monday, extending losses to a second back-to-back trading day, amid losses in financial, oil & gas and FMCG shares though gains in IT stocks lent some support. Global markets saw mixed moves ahead of the release of minutes of the Fed's last meeting that could offer more clarity on the trajectory of hikes in benchmark interest rates.
Fri, Feb 10, 2023
Gainers and Losers: Snapping its two-day gaining streak, the 30-share BSE Sensex ended 123.52 points or 0.20 per cent lower at 60,682.70.
Wed, Jan 25, 2023
Cipla Ltd on Wednesday reported 9.93 per cent rise in consolidated net profit to ₹800.96 crore for the quarter ended December 2022. Cipla had earned a net profit of Rs 757 crore in the October-December quarter of the last financial year 2021-22. Watch full news in this video.
Cipla Q3 Results: The drug maker reported a 9.9 per cent year-on-year increase in net profit to Rs 801 crore for the October-December period and revenue growth of six per cent to Rs 5,810.1 crore — both missing analysts' estimates. Cipla shares extended their intraday losses after the earnings announcement.
Shares of Tata Motors and Bajaj Auto were trading flat with a positive bias at Rs 422.40 and Rs 3,693 per share on the NSE in the early morning session on Wednesday.
Mon, Dec 26, 2022
SBI, IndusInd Bank, Cipla may give returns up to 25 per cent on long-term months, say ICICI Securities and Motilal Oswal analysts as Indian shares bounced sharply after last week's bloodbath.
Wed, Dec 21, 2022
To review the Covid preparedness, Union Health Minister Mansukh Mandaviya chaired a meeting with top officials as fresh spurt in cases in countries like Japan, South Korea, Brazil, China, and the US.
Fri, Dec 09, 2022
Stocks to buy: One may consider the brokerage recommendations for positive yield.
Thu, Nov 24, 2022
Nifty, Sensex, Top Gainers, Top Losers, Apollo Hospital, Infosys, Cipla: According to the market analyst, the rally in the final hour can be attributed to a quick covering move as call writers were trapped.
Mon, Nov 07, 2022
Shares of Cipla Ltd (NSE: CIPLA) corrected in the D street on Nov 7. The downtrend follows despite the third-largest pharma company in India reporting a consolidated net profit increase of 12%.
Cipla Share Price: Drug major Cipla posted its consolidated net profit of Rs 797 crore, an increase of 12 per cent for the second quarter ended September 30 on the back of robust sales across domestic and the US market.
Fri, Nov 04, 2022
Its total revenue from operations rose to Rs 5,829 crore for the September quarter from Rs 5,520 crore in the year-ago period, Cipla said in a regulatory filing.
Mon, Oct 03, 2022
The 30-share BSE Sensex fell 638.11 points or 1.11 per cent to settle at 56,788.81. The NSE Nifty went lower by 207 points or 1.21 per cent to end at 17,887.35.
In contrast to the benchmark indices, the pharma and healthcare indices surged in a weak market.
Sun, Aug 07, 2022
Cipla, the country's third largest drug maker, has 47 manufacturing sites around the world which cater to around 86 markets across the globe.
Mon, Aug 01, 2022
Pharmaceutical companies’ stocks such as Cipla, Zydus Wellness, and Torrent Pharma rose up to 5% on the BSE intraday trade.
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
